Authors:
STRAUS DJ
HUANG J
TESTA MA
LEVINE AM
KAPLAN LD
Citation: Dj. Straus et al., PROGNOSTIC FACTORS IN THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA - ANALYSIS OF AIDS CLINICAL-TRIALS GROUP PROTOCOL-142 - LOW-DOSE VERSUS STANDARD-DOSE M-BACOD PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Journal of clinical oncology, 16(11), 1998, pp. 3601-3606
Authors:
STRAUS DJ
HUANG J
TESTA MA
LEVINE AM
KAPLAN LD
Citation: Dj. Straus et al., PROGNOSTIC FACTORS IN THE TREATMENT OF HIV-ASSOCIATED NON-HODGKIN-LYMPHOMA (HANHL) - ANALYSIS OF ACTG-142 (LOW-DOSE VS STANDARD-DOSE MBACOD-CSF)(GM), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 89-89
Authors:
KAPLAN LD
STRAUS DJ
TESTA MA
VONROENN J
DEZUBE BJ
COOLEY TP
HERNDIER B
NORTHFELT DW
HUANG J
TULPULE A
LEVINE AM
Citation: Ld. Kaplan et al., LOW-DOSE COMPARED WITH STANDARD-DOSE M-BACOD CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 336(23), 1997, pp. 1641-1648
Authors:
MOSKOWITZ CH
NIMER SD
PORTLOCK CS
STRAUS DJ
PEARSE R
OBRIEN JP
BERGER M
GARDNER S
TRIPPETT TM
ZELENETZ AD
YAHALOM J
Citation: Ch. Moskowitz et al., IFOSFAMIDE (I), CARBOPLATIN (C) AND ETOPOSIDE (E) (ICE) CYTOREDUCTIONFOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND ASCT FOR REFRACTORY AND RELAPSED HODGKINS-DISEASE (HD) - AN INTENT TO TREAT STUDY, Blood, 90(10), 1997, pp. 1025-1025
Citation: Dj. Straus, TREATMENT OF HODGKINS-DISEASE - THE ROLE OF RADIOTHERAPY AND OR CHEMOTHERAPY IN ADVANCED STAGES/, Bailliere's clinical haematology, 9(3), 1996, pp. 553-558
Authors:
HIRSCH A
VANDERELS N
STRAUS DJ
GOMEZ EG
LEUNG D
PORTLOCK CS
YAHALOM J
Citation: A. Hirsch et al., EFFECT OF ABVD CHEMOTHERAPY WITH AND WITHOUT MANTLE OR MEDIASTINAL IRRADIATION ON PULMONARY-FUNCTION AND SYMPTOMS IN EARLY-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 14(4), 1996, pp. 1297-1305
Authors:
POPPELWELL LL
FILIPPA D
PORTLOCK CS
STRAUS DJ
YAHALOM J
OBRIEN JP
ZELENETZ AD
MOSKOWITZ CH
Citation: Ll. Poppelwell et al., ANALYSIS OF TREATMENT STRATEGY AND SURVIVAL IN PATIENTS WITH LYMPHOCYTE PREDOMINANT HODGKINS-DISEASE, Blood, 88(10), 1996, pp. 355-355
Authors:
FILIPPA DA
LADANYI M
WOLLNER N
STRAUS DJ
OBRIEN JP
PORTLOCK C
GANGI M
SUN M
Citation: Da. Filippa et al., CD30 (KI-1)-POSITIVE MALIGNANT-LYMPHOMAS - CLINICAL, IMMUNOPHENOTYPIC, HISTOLOGIC, AND GENETIC-CHARACTERISTICS AND DIFFERENCES WITH HODGKINS-DISEASE, Blood, 87(7), 1996, pp. 2905-2917
Authors:
GAYNOR JJ
FEUER EJ
TAN CC
WU DH
LITTLE CR
STRAUS DJ
CLARKSON BD
BRENNAN MF
Citation: Jj. Gaynor et al., ON THE USE OF CAUSE-SPECIFIC FAILURE AND CONDITIONAL FAILURE PROBABILITIES - EXAMPLES FROM CLINICAL ONCOLOGY DATA, Journal of the American Statistical Association, 88(422), 1993, pp. 400-409
Authors:
YAHALOM J
GULATI SC
TOIA M
MASLAK P
MCCARRON EG
OBRIEN JP
PORTLOCK CS
STRAUS DJ
PHILLIPS J
FUKS Z
Citation: J. Yahalom et al., ACCELERATED HYPERFRACTIONATED TOTAL-LYMPHOID IRRADIATION, HIGH-DOSE CHEMOTHERAPY, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORYAND RELAPSING PATIENTS WITH HODGKINS-DISEASE, Journal of clinical oncology, 11(6), 1993, pp. 1062-1070
Authors:
CZUCZMAN MS
STRAUS DJ
DIVGI CR
GRAHAM M
GARINCHESA P
FINN R
MYERS J
OLD LJ
LARSON SM
SCHEINBERG DA
Citation: Ms. Czuczman et al., PHASE-I DOSE-ESCALATION TRIAL OF IODINE 131-LABELED MONOCLONAL-ANTIBODY OKB7 IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 11(10), 1993, pp. 2021-2029